Literature DB >> 2823974

Preoptic area opioids and opiate receptors increase during pregnancy and decrease during lactation.

R P Hammer1, R S Bridges.   

Abstract

Opiate receptor and endogenous opioid content were determined in pregnant, lactating, ovariectomized, and ovariectomized and subsequently estradiol- and progesterone-treated adult female rats. Levels of estradiol and progesterone produced by Silastic capsules implanted in animals of the ovariectomized, hormone-treated group were similar to natural levels of those hormones induced during pregnancy. Quantitative receptor autoradiography and radioimmunoassay were used to determine [3H]naloxone binding density and immunoreactive beta-endorphin content, respectively, in the preoptic area of the hypothalamus. Both opiate receptor binding density and beta-endorphin content in the preoptic area varied in the same direction in all experimental groups. The highest levels of both were observed during pregnancy and the lowest levels during lactation. Ovariectomy without subsequent hormone treatment produced intermediate levels of both opiate receptor and beta-endorphin. Ovariectomy with experimentally-induced estradiol and progesterone levels similar to those of pregnancy produced opiate receptor density and beta-endorphin content similar to those observed in pregnant animals. These data suggest that gonadal steroids are capable of altering function of the endogenous opiate system in the preoptic area. Moreover, preoptic area levels of opioids and opiate receptors are normally elevated during pregnancy and reduced during lactation. Since opiates are known to disrupt ongoing maternal behavior, a reduction of preoptic opiate function during lactation may be required to promote normal maternal behavior. The specific preoptic region involved in opiate regulation of maternal behavior may be illustrated by the zone of opiate receptor alteration observed herein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823974     DOI: 10.1016/0006-8993(87)90238-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Gene array profiling of large hypothalamic CNS regions in lactating and randomly cycling virgin mice.

Authors:  Stephen C Gammie; Nina S Hasen; Tarif A Awad; Anthony P Auger; Heather M Jessen; Jules B Panksepp; Anne M Bronikowski
Journal:  Brain Res Mol Brain Res       Date:  2005-10-03

2.  Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Authors:  Yolanda R Smith; Christian S Stohler; Thomas E Nichols; Joshua A Bueller; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

3.  Estrogen modulation of peripheral pain signal transduction: involvement of P2X(3) receptors.

Authors:  Bei Ma; Li-Hua Yu; Juan Fan; Binhai Cong; Ping He; Xin Ni; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

4.  Estrogen augments hypothalamicβ-endorphin secretion and activates an inhibitoryβ-endorphin short-loop feedback system.

Authors:  S A Frautschy; D K Sarkar
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

5.  Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats.

Authors:  Cláudia M Miranda-Paiva; Antonia G Nasello; Alberto J Yim; Luciano F Felicio
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

6.  Acute HPA axis response to naltrexone differs in female vs. male smokers.

Authors:  Daniel J O Roche; Emma Childs; Alyssa M Epstein; Andrea C King
Journal:  Psychoneuroendocrinology       Date:  2009-10-17       Impact factor: 4.905

7.  Morphine effects on maternal aggression, pup care and analgesia in mice.

Authors:  M Haney; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Testosterone modulation of ethanol effects on the µ-opioid receptor kinetics in castrated rats.

Authors:  Rafaat Khalil; Jessica Humann
Journal:  Biomed Rep       Date:  2019-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.